Adverse drug reactions to antitubercular therapy in osteoarticular tuberculosis: a retrospective observational study from a tertiary care center
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20252580Keywords:
Osteoarticular tuberculosis, Antitubercular therapy, Adverse drug reactions, Retrospective study, Extrapulmonary tuberculosis, Treatment adherence, Tertiary care centerAbstract
Background: Osteoarticular tuberculosis (OATB) is a challenging form of extrapulmonary tuberculosis (TB) that often requires long-term multidrug regimens. Antitubercular therapy (ATT) can lead to significant adverse drug reactions (ADRs), potentially affecting patient adherence and outcomes. Objectives were to assess the types and frequencies of ATT-induced ADRs in patients treated for osteoarticular TB.
Methods: This retrospective observational study included 27 patients diagnosed with OATB, who were treated at Dr. RPGMC Tanda. Patient records and telephone interviews were used to collect data on ADRs. Descriptive statistics were used for analyses.
Results: Of 27 patients, 13 (48.1 %) experienced ADRs. GI symptoms were the most common (18.5%), followed by dermatological (11.1%) and neurological (11.1%) side effects. One case each of hepatotoxicity with liver failure and epistaxis, and two cases of ocular symptoms were recorded.
Conclusions: Nearly half of the patients developed ADRs to ATT. Regular monitoring and early intervention are essential to improve treatment compliance and patient safety.
Metrics
References
Romanò CL, Drago L, Del Sel H, Johari A, Lob G, Mavrogenis AF, et. al. World Association against Infection in Orthopedics and Trauma (WAIOT) Study Group on Bone and Joint Infection Definitions. Loud and silent epidemics in the third millennium: tuning-up the volume. Int Orthopaed. 2020;44(6):1019-22. DOI: https://doi.org/10.1007/s00264-020-04608-8
WHO. Global Tuberculosis Report, 2019. Available at: https://www.who.int/publicationsbatuberculosis-report2019. Accessed on 09 June 2025.
Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120(4):316-53.
Tuli SM. General principles of osteoarticular tuberculosis. Clin Orthop Relat Res. 2002;(398):11-9. DOI: https://doi.org/10.1097/00003086-200205000-00003
Tuli SM. Tuberculosis of the Skeletal System. 4th ed. Jaypee Brothers Medical Publishers. 2010. DOI: https://doi.org/10.5005/jp/books/11046
Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, et. al. Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India. Indian J Med Res. 2017;145(4):448-63. DOI: https://doi.org/10.4103/ijmr.IJMR_1950_16
Forget EJ, Menzies D. Adverse reactions to first-line anti-tuberculosis drugs. Expert Opin Drug Saf. 2006;5(2):231-49. DOI: https://doi.org/10.1517/14740338.5.2.231
Kim SH. Severe Cutaneous Adverse Reactions Caused by Antitubercular Drugs. Allergy Asthma Immunol Res. 2021;13(2):173-6. DOI: https://doi.org/10.4168/aair.2021.13.2.173
Koju D, Rao BS, Shrestha B, Shakya R, Makaju R. Occurrence of side effects from anti-tuberculosis drugs in urban Nepalese population under DOTS treatment. Kathmandu University J Sci Eng Technol. 2005;1(1):1-8. DOI: https://doi.org/10.3126/kuset.v1i1.64289
Kass JS, Shandera WX. Nervous system effects of anti-tuberculosis therapy. CNS Drugs. 2010;24(8):655-67. DOI: https://doi.org/10.2165/11534340-000000000-00000
Singh P, Karkhur S, Verma V. Ethambutol-induced optic neuropathy: a retrospective study of incidences and risk factors. Cureus. 2025;17(2):e79160. DOI: https://doi.org/10.7759/cureus.79160
Downloads
Published
How to Cite
Issue
Section
